In the past few years, emerging new biomarkers for early diagnosis of AD have been found, among which, the level of Ng in CSF of AD patients is significantly positively correlated with CSF total Tau and phosphorylated tau27,31,32,41,47,48, but the reports of the relationship with Aβ is inconsistent. This evidence concerns the gene MAPT and Alzheimer disease.